Live Quote · NASDAQTRVIHealthcare· Biotechnology

Trevi Therapeutics, Inc.

$13.35▼ 2.70%($-0.37)
MKT CAP $1.90BNEXT EARNINGS Mar 16, 2027
50%
Bullish
TickerSpark Score
48/100
▌ Weak
47
Valuation
20
Profitability
60
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TRVI research report →

Analyst Price Target
$29.60+121.7% vs. today

Range $23 – $40

Analyst RatingBuy
18 Buy0 Hold0 Sell

Price Chart

+24.28% · this period
$19.50$14.75$9.99Nov 19May 22Nov 19
52-Week Range34% of range
Low
$9.82
Current
$13.35
High
$20.22